Literature DB >> 18543250

A PPARs cross-talk concertedly commits C6 glioma cells to oligodendrocytes and induces enzymes involved in myelin synthesis.

Andrea V Leisewitz1, Carolina R Urrutia, Gabriela R Martinez, Gloria Loyola, Miguel Bronfman.   

Abstract

Peroxisome proliferator activated receptors (PPARs, alpha, beta/delta, gamma) control lipid homeostasis and differentiation in various tissues and tumor cells. PPARbeta and PPARgamma increase oligodendrocyte maturation in glial mixed populations and spinal cord oligodendrocytes, respectively, and PPARbeta is known to modulate the activity of other PPARs. To assess a possible interaction between PPARs in glial cell differentiation we used the undifferentiated C6 glioma cell line as model. These cells express all three PPARs, but only PPARgamma shows transcriptional activity in agonist-based reporter gene assay. Agonist-activated PPARgamma up-regulates oligodendrocyte markers, down-regulates an astrocyte marker, and increases alkyl-dihydroxyacetone phosphate synthase, enzyme involved in the synthesis of myelin-rich plasmalogens. Similar effects are induced in PPARgamma overexpressing cells, which in addition show PPARbeta up-regulation. PPARbeta or PPARalpha agonists show no effect. Nevertheless, PPARbeta overexpression up-regulates PPARgamma and commits C6 cells to oligodendrocytes; effect that is abrogated by a PPARgamma antagonist or PPARgamma interference RNA. Moreover, PPARbeta overexpression also induces PPARalpha and its target genes, including acyl-CoA oxidase, enzyme involved in very long chain fatty acid recycling, and in the synthesis of myelin components such as docosahexaenoic acid. These results indicate for the first time, that PPARs concertedly cooperate in C6 glioma cell differentiation to oligodendrocytes. Further, they suggest that active PPARbeta might be essential for increasing oligodendrocyte distinctive markers and enzymes required for myelin synthesis in C6 glioma cells through up-regulation of PPARgamma and PPARalpha. (c) 2008 Wiley-Liss, Inc

Entities:  

Mesh:

Substances:

Year:  2008        PMID: 18543250     DOI: 10.1002/jcp.21509

Source DB:  PubMed          Journal:  J Cell Physiol        ISSN: 0021-9541            Impact factor:   6.384


  11 in total

1.  Type II arginine methyltransferase PRMT5 regulates gene expression of inhibitors of differentiation/DNA binding Id2 and Id4 during glial cell differentiation.

Authors:  Jinghan Huang; Gillian Vogel; Zhenbao Yu; Guillermina Almazan; Stéphane Richard
Journal:  J Biol Chem       Date:  2011-10-31       Impact factor: 5.157

2.  Serum choline plasmalogens, particularly those with oleic acid in sn-2, are associated with proatherogenic state.

Authors:  Megumi Nishimukai; Ryouta Maeba; Yuya Yamazaki; Toru Nezu; Toshihiro Sakurai; Yuji Takahashi; Shu-Ping Hui; Hitoshi Chiba; Tomoki Okazaki; Hiroshi Hara
Journal:  J Lipid Res       Date:  2014-03-10       Impact factor: 5.922

Review 3.  Peroxisome proliferator-activated receptor γ (PPARγ): A master gatekeeper in CNS injury and repair.

Authors:  Wei Cai; Tuo Yang; Huan Liu; Lijuan Han; Kai Zhang; Xiaoming Hu; Xuejing Zhang; Ke-Jie Yin; Yanqin Gao; Michael V L Bennett; Rehana K Leak; Jun Chen
Journal:  Prog Neurobiol       Date:  2017-10-12       Impact factor: 11.685

Review 4.  PPARalpha: an emerging therapeutic target in diabetic microvascular damage.

Authors:  Anne Hiukka; Marianna Maranghi; Niina Matikainen; Marja-Riitta Taskinen
Journal:  Nat Rev Endocrinol       Date:  2010-06-22       Impact factor: 43.330

Review 5.  Could dietary erucic acid lower risk of brain tumors? An epidemiological look to Chinese population with implications for prevention and treatment.

Authors:  Meric A Altinoz
Journal:  Metab Brain Dis       Date:  2022-06-15       Impact factor: 3.584

Review 6.  Nuclear hormone receptors in demyelinating diseases.

Authors:  Rocío I Zorrilla Veloz; Takese McKenzie; Bridgitte E Palacios; Jian Hu
Journal:  J Neuroendocrinol       Date:  2022-06-22       Impact factor: 3.870

7.  Co-Ultramicronized Palmitoylethanolamide/Luteolin Restores Oligodendrocyte Homeostasis via Peroxisome Proliferator-Activated Receptor-α in an In Vitro Model of Alzheimer's Disease.

Authors:  Roberta Facchinetti; Marta Valenza; Chiara Gomiero; Giulia Federica Mancini; Luca Steardo; Patrizia Campolongo; Caterina Scuderi
Journal:  Biomedicines       Date:  2022-05-26

8.  MeCP2 Differentially Regulate the Myelin MBP and PLP Protein Expression in Oligodendrocytes and C6 Glioma.

Authors:  Kedarlal Sharma; Juhi Singh; Prakash P Pillai
Journal:  J Mol Neurosci       Date:  2018-07-10       Impact factor: 3.444

Review 9.  PPAR agonists as therapeutics for CNS trauma and neurological diseases.

Authors:  Shweta Mandrekar-Colucci; Andrew Sauerbeck; Phillip G Popovich; Dana M McTigue
Journal:  ASN Neuro       Date:  2013-12-18       Impact factor: 4.146

10.  Proteomic Analysis of Perihematoma Tissue from Patients with Intracerebral Hemorrhage Using iTRAQ-Based Quantitative Proteomics.

Authors:  Bin Chen; Mingjian Liu; Zhenghong Chen; Xiaorong Gao; Yijun Cheng; Yongxu Wei; Zhebao Wu; Hanbing Shang
Journal:  Neuromolecular Med       Date:  2021-01-03       Impact factor: 3.843

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.